Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
Journal Article
Tsirona, S., Katsaros F., Bargiota A., Polyzos S. A., Arapoglou G., & Koukoulis G. N. (2016).  Prevalence and determinants of type 2 diabetes mellitus in a Greek adult population.. Hormones (Athens). 15(1), 88-98.
Anagnostis, P., Adamidou F., Polyzos S. A., Katergari S., Karathanasi E., Zouli C., et al. (2013).  Predictors of long-term remission in patients with Graves' disease: a single center experience.. Endocrine. 44(2), 448-53.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2011).  The potentially dual-faceted nature of fetuin-A in Helicobacter pylori infection and insulin resistance.. Clinics (Sao Paulo). 66(5), 911-2.
Kapetanakis, N., Kountouras J., Zavos C., Anastasiadou K., Tsarouchas G., Michael S., et al. (2013).  Potential oncogenic properties of mobilized stem cells in a subpopulation of inflammatory bowel disease patients infected with Helicobacter pylori.. Inflamm Bowel Dis. 19(2), E27-9.
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Kountouras C., Vardaka E., et al. (2016).  Potential molecular aspects of Helicobacter pylori-related hyperplastic polyp development and progression.. Eur J Gastroenterol Hepatol. 28(7), 851-2.
Kountouras, J., Zavos C., Deretzi G., Gavalas E., Chatzopoulos D., Katsinelos P., et al. (2012).  Potential implications of Helicobacter pylori-related neutrophil-activating protein.. World J Gastroenterol. 18(5), 489-90.
Kountouras, J., Kazakos E., Polyzos S. A., Papaefthymiou A., Zavos C., Tzitiridou-Chatzopoulou M., et al. (2023).  Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease.. Clin Immunol. 256, 109776.
Kountouras, J., Papaefthymiou A., Polyzos S. A., & Doulberis M. (2021).  A potential impact of Helicobacter pylori-related sarcopenia on severity of portal hypertension.. Liver Int.
Kountouras, J., Doulberis M., Polyzos S. A., Tzitiridou M., Chatzopoulos D., Gialamprinou D., et al. (2022).  A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery.. Gastrointest Endosc. 96(6), 1088-1089.
Kountouras, J., Polyzos S. A., Doulberis M., Zeglinas C., Artemaki F., Vardaka E., et al. (2018).  Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis.. Metabolism. 87, 18-24.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kyrailidi F., & Doulberis M. (2022).  Potential impact of Helicobacter pylori-related metabolic syndrome on arterial hypertension outcomes.. Am J Hypertens.
Boziki, M., Polyzos S. A., Papaefthymiou A., Doulberis M., Bakirtzis C., Sintila S-A., et al. (2021).  Potential impact of Helicobacter pylori-related metabolic syndrome and Galectin-3 on liver, chronic kidney and brain disorders.. Metabolism. 154736.
Kountouras, J., Zavos C., Polyzos S. A., & Deretzi G. (2016).  Potential impact of Helicobacter pylori-related human β-defensin-1 on hepatic encephalopathy and neurodegeneration.. Ann Gastroenterol. 29(1), 99.
Boziki, M., Grigoriadis N., Doulberis M., Papaefthymiou A., Polyzos S. A., & Kountouras J. (2020).  Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosis.. Dig Liver Dis. 52(1), 121-123.
Boziki, M., Polyzos S. A., Deretzi G., Kazakos E., Katsinelos P., Doulberis M., et al. (2018).  A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration.. Neurochem Int. 113, 137-151.
Kountouras, J., Polyzos S. A., Katsinelos P., Anastasiadis S., Tzivras D., Doulberis M., et al. (2018).  Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.. Dig Dis Sci. 63(4), 1087-1088.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Zavos C., Vagdatli E., et al. (2020).  Potential Impact of Helicobacter pylori Infection on Reflux Disease Sequence: Illuminating the Gap.. J Clin Gastroenterol. 54(2), 200-201.
Kountouras, J., Papaefthymiou A., Polyzos S. A., & Doulberis M. (2022).  Potential Impact of Helicobacter pylori Infection on Pancreatic Cancer Pathophysiology.. J Gastrointest Cancer.
Kountouras, J., Polyzos S. A., Gavalas E., Boziki M., Katsinelos P., Zeglinas C., et al. (2016).  A potential impact of Helicobacter pylori infection on minimal hepatic encephalopathy pathobiology.. J Gastrointestin Liver Dis. 25(3), 405-6.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Tzilves D., Lazaraki G., et al. (2023).  Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B.. J Viral Hepat.
Kountouras, C., Polyzos S. A., Stergiopoulos C., Katsinelos P., Tzivras D., Zavos C., et al. (2017).  A potential impact of Helicobacter pylori infection on both obstructive sleep apnea and atrial fibrillation-related stroke.. Sleep Med. 34, 256.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Tzitiridou-Chatzopoulou M., Chatzopoulos D., et al. (2022).  Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease.. Metabolism. 135, 155276.
Kountouras, J., Doulberis M., Polyzos S. A., Papaefthymiou A., Kapetanakis N., Arapoglou S., et al. (2018).  Potential Impact of Active Helicobacter pylori Infection with or without Concomitant Metabolic Syndrome on Colorectal Cancer Invasion and Mortality.. Isr Med Assoc J. 20(11), 725-726.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2011).  The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature.. J Clin Gastroenterol. 45(1), 50-4.
Polyzos, S. A., Anastasilakis A. D., Efstathiadou Z. A., Yavropoulou M. P., & Makras P. (2021).  Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations.. Maturitas. 147, 19-25.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές